Antenatal Corticosteroids for Late-Preterm Infants: A Decision-Analytic and Economic Analysis

Table 1

Probabilities of acute adverse neonatal outcomes.

Adverse event	34 weeks	35 weeks	36 weeks
With corticosteroids
Acute respiratory disease	0.064 [2, 6, 12]; (0.02–0.104)	0.032 [2, 6, 12, 13]; (0.01–0.052)	0.0192 [2, 6, 12, 13]; (0.006–0.0312)
Without corticosteroids
Acute respiratory disease	0.1312 [2, 6, 12, 13]; (0.041–0.2132)	0.064 [2, 6, 12, 13]; (0.02–0.104)	0.032 [2, 6, 12, 13]; (0.01–0.052)